← SynDRA
Acrizanib
SynDRA canonical compound SYN1837440 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | vegfr inhibitor |
|---|
| Indication | macular degeneration |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- KDR INHIBITOR
- VEGFR inhibitor
Drug classes
- Ophthalmic Solutions
- Protein Kinase Inhibitors
Cross-references
Synonyms
- LHA510
- LHA-510
- F2CB8801I3
- acrizanibum
- RefChem:109406
- Acrizanib [INN]
- Acrizanib (LHA510)
- Acrizanib?
- MFCD31715417
- UNII-F2CB8801I3
- orb1689897
- SCHEMBL2498599
- GTPL12782
- C20H18F3N7O2
- EX-A3028
- EZB45399
- BDBM50270432
- s6763
- ZB1557
- AKOS037648575
- compound 35 [PMID: 29400470]
- AC-36313
- BS-14686
- DA-60783
- HY-109020
- CS-0030518
- T5373
- G16434
- Acrizanib hydrochloride
- SCHEMBL30360221
- UNII-96P75SW46E
- SCHEMBL16237415
Look up Acrizanib in the interactive SynDRA portal →